Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Deutsches Arzteblatt International
|
July 22, 2025
Increasing Relevance
Jonas Früh, Nora Isberner, Janina Zirkel, et al.
The Journal of Antimicrobial Chemotherapy
|
January 6, 2026
Model-based assessment of letermovir pharmacokinetics in allogeneic haematopoietic stem cell transplant recipients
Chrisoula Tahtsidou, Sabrina Kraus, Hartwig Klinker, et al.
Clinical Rheumatology
|
March 15, 2025
Fever of unknown origin in B-cell depleted patients: Have you considered Neoehrlichiosis?
Lea-Kristin Nagler, Marc Schmalzing, Nora Isberner, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 30, 2020
Quantification of letermovir in human serum using high-performance liquid chromatography with diode array detection
Nora Isberner, Fatemeh Aghai, Diana Schirmer, et al.
Journal of the Pediatric Infectious Diseases Society
|
April 25, 2020
Determination of Letermovir Serum Levels Can Be Useful in High-Risk Clinical Settings
Nora Isberner, Fatemeh Aghai, Diana Schirmer, et al.
Analytical and Bioanalytical Chemistry
|
November 6, 2020
Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma
Fatemeh Aghai, Sebastian Zimmermann, Max Kurlbaum, et al.
Cancer Chemotherapy and Pharmacology
|
September 10, 2021
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice-a prospective single-center trial
Nora Isberner, Sabrina Kraus, Götz Ulrich Grigoleit, et al.
The Journal of Antimicrobial Chemotherapy
|
September 2, 2021
Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapy
Nora Isberner, Ruth Van Daele, Hartwig Klinker, et al.
Pharmaceutics
|
December 23, 2022
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease Patients
Bettina Gerner, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, et al.
Cancers
|
October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma
Nora Isberner, Anja Gesierich, David Balakirouchenane, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Deutsches Arzteblatt International
|
July 22, 2025
Increasing Relevance
Jonas Früh, Nora Isberner, Janina Zirkel, et al.
The Journal of Antimicrobial Chemotherapy
|
January 6, 2026
Model-based assessment of letermovir pharmacokinetics in allogeneic haematopoietic stem cell transplant recipients
Chrisoula Tahtsidou, Sabrina Kraus, Hartwig Klinker, et al.
Clinical Rheumatology
|
March 15, 2025
Fever of unknown origin in B-cell depleted patients: Have you considered Neoehrlichiosis?
Lea-Kristin Nagler, Marc Schmalzing, Nora Isberner, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 30, 2020
Quantification of letermovir in human serum using high-performance liquid chromatography with diode array detection
Nora Isberner, Fatemeh Aghai, Diana Schirmer, et al.
Journal of the Pediatric Infectious Diseases Society
|
April 25, 2020
Determination of Letermovir Serum Levels Can Be Useful in High-Risk Clinical Settings
Nora Isberner, Fatemeh Aghai, Diana Schirmer, et al.
Analytical and Bioanalytical Chemistry
|
November 6, 2020
Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma
Fatemeh Aghai, Sebastian Zimmermann, Max Kurlbaum, et al.
Cancer Chemotherapy and Pharmacology
|
September 10, 2021
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice-a prospective single-center trial
Nora Isberner, Sabrina Kraus, Götz Ulrich Grigoleit, et al.
The Journal of Antimicrobial Chemotherapy
|
September 2, 2021
Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapy
Nora Isberner, Ruth Van Daele, Hartwig Klinker, et al.
Pharmaceutics
|
December 23, 2022
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease Patients
Bettina Gerner, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, et al.
Cancers
|
October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma
Nora Isberner, Anja Gesierich, David Balakirouchenane, et al.
Page
of 2